Rigetti Slides 9% as Quantinuum IPO Resets Quantum Valuations

What happened

Rigetti shares dropped 9% after Quantinuum's IPO drew investor focus, reframing quantum sector valuations. The DeepValue report maintains a WAIT rating, noting Rigetti's $20.70 price prices government validation before the CHIPS LOI becomes binding. Near-term catalysts include converting the LOI into definitive agreements, deploying an $8.4M system to C-DAC in 2H 2026, and improving 108Q fidelity from ~99.1% to ~99.5%. Risks include dilution from a 15% discounted equity issuance tied to the LOI and management's history of missed milestones. Until at least one of these binary catalysts resolves, the stock remains a speculative bet on policy momentum rather than fundamentals.

Implication

Investors should monitor three key events over the next 6–12 months: definitive award agreements for the CHIPS LOI, the 2H 2026 C-DAC on-prem deployment, and progress toward ~99.5% two-qubit fidelity. The current price embeds optimism about government backing without factoring in the dilution risk from the 15% discounted equity pricing mechanism. If the LOI fails to convert or milestones slip, the stock could reprice toward the bear case of $12. Conversely, successful execution could justify the bull case of $32. Given the binary nature and the crowded narrative, a disciplined wait-and-see approach improves risk-adjusted returns.

Thesis delta

The Quantinuum IPO introduces a competitive valuation benchmark that may pressure Rigetti's premium if it fails to match progress. While the narrative around government validation persists, the market is now more focused on tangible milestones versus sector sympathy. This sharpens the importance of Rigetti's upcoming execution on the LOI conversion and fidelity targets.